🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

MPT to gain $200 million from healthcare assets sale

Published 11/08/2024, 09:14 PM
MPW
-

BIRMINGHAM, Ala. - Medical Properties Trust, Inc. (NYSE:MPW), a prominent real estate investment trust specializing in hospital properties, announced it has entered into a definitive agreement with Astrana Health, a California-based healthcare company. The deal, valued at approximately $745 million, involves the sale of the majority of Prospect's managed care platform, with MPT expecting to net about $200 million in cash proceeds after settling debts and other liabilities.

The majority of the cash proceeds for MPT is anticipated in the first half of 2025, with an additional $50 million expected by 2027. Completion of the transaction is contingent upon regulatory approvals and customary closing conditions.

Medical (TASE:PMCN) Properties Trust, which was established in 2003 and is headquartered in Birmingham, Alabama, has grown significantly to become one of the largest owners of hospital real estate globally. As of September 30, 2024, the company's portfolio includes 402 facilities and roughly 40,000 licensed beds across nine countries on three continents. MPT's financial model supports hospital operators by enabling them to leverage their real estate assets to invest in improvements and technological advancements.

The press release includes forward-looking statements that are subject to various risks and uncertainties. Factors that could affect actual results include the outcome of bankruptcy restructuring, the company's ability to successfully re-tenant hospital facilities, and the completion of property sales and capital transactions as planned. These forward-looking statements are based on current expectations and involve known and unknown risks.

This announcement is based on a press release statement from Medical Properties Trust, Inc. and does not include any speculative information or broader industry impacts. The news reflects MPT's ongoing strategy to manage its healthcare real estate assets and the financial implications of its latest transaction with Astrana Health.

In other recent news, Medical Properties Trust (MPT) reported its third-quarter financial results for 2024, which were characterized by strategic moves such as a global settlement with Steward Health Care System LLC. This settlement allowed MPT to regain control over its real estate assets and transition several facilities' operations. Despite a GAAP net loss of $1.34 per share, MPT's normalized funds from operations stood at $0.16 per share. The company also reported asset sales totaling approximately $2.9 billion year-to-date, aimed at enhancing liquidity and financial flexibility.

MPT also reached an agreement with College Health to lease the St. Luke's campus in Phoenix, a move expected to boost annual cash rent. The company sold 18 emergency departments and a general acute care hospital for about $246 million. In addition, the Swiss Medical Network reported a 10% year-over-year earnings growth. Furthermore, MPT maintains a strong liquidity position with a cash balance of $275 million and $880 million in revolver capacity.

Looking forward, MPT expects to stabilize operations and enhance profitability through the transition of facilities. The successful re-tenanting of 17 properties is projected to gradually increase cash rent to $160 million by the end of 2026. The company's total annualized cash rent is expected to exceed $1 billion once these properties are fully operational.

InvestingPro Insights

Medical Properties Trust's recent agreement with Astrana Health aligns with the company's strategic asset management approach, as reflected in the latest InvestingPro data. Despite the company's recent challenges, including a significant revenue decline of 53.76% over the last twelve months, MPW maintains a strong gross profit margin of 96.83%, underscoring its operational efficiency in managing healthcare real estate.

InvestingPro Tips highlight that MPW "pays a significant dividend to shareholders" and "has maintained dividend payments for 20 consecutive years." This commitment to shareholder returns is evident in the current dividend yield of 7.05%, although it's worth noting that dividend growth has decreased by 72.41% in the last twelve months. This could be a reflection of the company's efforts to balance shareholder returns with financial stability during a period of portfolio restructuring.

The company's focus on long-term value creation is further supported by another InvestingPro Tip indicating that "net income is expected to grow this year." This positive outlook, combined with the anticipated cash proceeds from the Astrana Health deal, suggests that MPW is positioning itself for potential financial improvement.

For investors seeking a more comprehensive analysis, InvestingPro offers 8 additional tips that could provide deeper insights into MPW's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.